Human medicines European public assessment report EPAR Flixabi infliximab Spondylitis AnkylosingArthritis RheumatoidCrohn DiseaseColitis UlcerativeArthritis PsoriaticPsoriasis Date of authorisation 26052016 Revision 8 Status Authorised
↧